IP Verse

Pharmaceutical Formulation Comprising Ezetimibe - EP2217214

The patent EP2217214 was granted to Ratiopharm on Jul 19, 2017. The application was originally filed on Dec 9, 2008 under application number EP08859677A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2217214

RATIOPHARM
Application Number
EP08859677A
Filing Date
Dec 9, 2008
Status
Granted And Under Opposition
Jun 16, 2017
Grant Date
Jul 19, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BULLE DRApr 19, 2018BULLEADMISSIBLE
WITTKOPPApr 19, 2018HAMM & WITTKOPPADMISSIBLE
HOFFMANN EITLEApr 18, 2018HOFFMANN EITLEADMISSIBLE
HGFApr 16, 2018HGFADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2007275052
INTERNATIONAL-SEARCH-REPORTWO2007103453
INTERNATIONAL-SEARCH-REPORTWO9508532
OPPOSITIONEP1353696
OPPOSITIONUS2007049748
OPPOSITIONUS2007275052
OPPOSITIONWO2006060808
OPPOSITIONWO2007003365
OPPOSITIONWO2007103453
OPPOSITIONWO2008032338
OPPOSITIONWO2008089484
OPPOSITIONWO2008089984
OPPOSITIONWO2008101723
OPPOSITIONWO9508532
OTHERWO2006060808
OTHERWO2008032338
OTHERWO2009077573

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- CHAUMEIL J C, "MICRONIZATION: A METHOD OF IMPROVING THE BIOAVAILABILITY OF POORLY SOLUBLE DRUGS", METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, PROUS, BARCELONA, ES, (19980401), vol. 20, no. 3, ISSN 0379-0355, pages 211 - 215, XP009048140 [A] 1-30 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- "ZETIA (EZETIMIBE) TABLETS", INTERNET CITATION, URL: http://www.fda.gov/cder/foi/label/2002/21445lbl.pdf, (20060728), XP002392710 [A] 1-30 * the whole document *-
OPPOSITION- "8 Gastrointestinal Dissolution and Absorption of Drugs", H. VAN DE WATERBEEND et al., Drug Bioavailability, pages 204 - 208, XP055493352-
OPPOSITION- Anonymous, "MASTERSIZER 3000", Malvern Instruments, (20160000), pages 1 - 20, URL: https://www.malvernpanalytical.com/en/assets/MRK1872-06-EN_MS3000_Broch_INTERACT_12-2016_tcm50-17232.pdf, XP055493335-
OPPOSITION- A. TAMMARO et al., "Magensium stearate: an underestimated allergen", Pubmed, (20121000), XP055493342-
OPPOSITION- FAO JECFA Monographs 17 - Magnesium Stearate-
OPPOSITION- J.C. CHAUMEIL, "Micronization: a method of improving the bioavailability of poorly soluble drugs.", Meth Find Exp Clin Pharmacol, (19980000), vol. 20, no. 3, pages 211 - 215, XP009048140-
OPPOSITION- "Key factors influencing measured tablet hardness", Pharmatron, (20110520), URL: http://www.pharmatron.com/newsroom/news/article/key-factors-influencing-measured-tablet-hardness/, XP055493339-
OPPOSITION- P.H. LIST et al., "23.4 Wirkungsbeeinflussung bei den Oralia", Arzneiformenlehre Ein Lehrbuch für Pharmazeuten, WVG Stuttgart, (19850000), pages 529 - 530, XP055493343-
OPPOSITION- P York, "Extracts Chapter 1 and 9", P York, M.E. AULTON, Pharmaceutics: The Science of Dosage Form Design, Churchill Livingstone, pages 1 - 13, 135-173, XP055493348-
OPPOSITION- "Starch", Rowe R. c. et al, Handbook of pharmaceutical excipients. 5 th ed., PhP, (20060000), pages 725 - 730, XP055480758-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents